MiniMed Group, Inc. (MMED)

Revenue

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Pumps Revenue	541.00M	540.00M
Pumps Revenue Growth	0.18%	13.21%
Consumables Revenue	854.00M	777.00M
Consumables Revenue Growth	9.91%	2.24%
Continuous Glucose Monitoring (CGM) Revenue	1.31B	1.12B
Continuous Glucose Monitoring (CGM) Revenue Growth	17.55%	16.60%
Other Segment Revenue	6.00M	34.00M
Other Segment Revenue Growth	-82.35%	-32.00%
Revenue (Other)	1.00M	1.00M
Revenue (Total)	2.72B	2.47B
Revenue (Total) Growth	9.96%	9.98%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
United States Revenue	903.00M	833.00M
United States Revenue Growth	8.40%	0.12%
International Revenue	1.81B	1.64B
International Revenue Growth	10.76%	15.78%
Revenue (Total)	2.72B	2.47B
Revenue (Total) Growth	9.96%	9.98%

Key Performance Indicators

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
US - Organic Revenue Growth	8.40%	-
International - Organic Revenue Growth	13.10%	13.60%
Total Organic Revenue Growth	11.50%	8.60%

Updated Apr 17, 2026. Data Source: Fiscal.ai.